The Itch: Allergies, Asthma, Eczema & Immunology cover art

The Itch: Allergies, Asthma, Eczema & Immunology

The Itch: Allergies, Asthma, Eczema & Immunology

By: The Itch: Allergies Asthma & Immunology
Listen for free

About this listen

A podcast bringing you easily digestible information on all things allergies, asthma eczema, and immunologyCopyright 2018 All rights reserved. Hygiene & Healthy Living Physical Illness & Disease Social Sciences
Episodes
  • #139 - Understanding Food Allergy Labels & "May Contain" in the U.S.
    Dec 22 2025

    Reading food labels can feel like a full-time job when you or your child has food allergies. Even when you know what to avoid, labels can still be confusing, especially when you run into “may contain” warnings.

    Marion Groetch, a registered dietitian with decades of experience in food allergy care and education, joins us to unpack all things food labels. Together, we break down U.S. allergen labeling laws, what parts of the package actually matter, and why “may contain” statements are a much grayer area than most people realize. We also share practical tips for navigating so-called “mystery ingredients” like natural flavors and oils, when it is worth contacting a manufacturer, and how to avoid being more restrictive than necessary while still staying safe.

    What we cover in our episode about food labels:
    • What U.S. labeling laws require: How FALCPA and the FASTER Act protect families by requiring clear disclosure of the Top 9 major allergens.
    • Where allergy information actually lives on a label: Why the ingredients list and “Contains” statement matter most, and why front-of-package claims should be ignored.
    • What “may contain” actually means: Why these statements are voluntary and unregulated, and what that means for real-world decision-making.
    • Foods that fall outside labeling laws: Common situations where allergen labeling is not required, including deli foods, restaurant meals, airline meals, and alcohol.
    • How to avoid over-restricting your diet: Practical guidance on mystery ingredients, higher-risk products, and when contacting a manufacturer actually makes sense.

    ___

    Made in partnership with The Allergy & Asthma Network.

    Thanks to Genentech for sponsoring today’s episode.

    This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

    Show More Show Less
    39 mins
  • #138 - Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation
    Dec 5 2025

    Clonal mast cell disease is often missed because symptoms vary from person to person, tryptase levels can be normal, and bone marrow biopsies are hard to get. For some people, unexplained or very severe anaphylaxis may be an early sign of a clonal mast cell disease.

    In this episode, we review “Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation,” published in October 2025 in the Journal of Allergy and Clinical Immunology. This paper, known as the PROSPECTOR trial, is looking at how often the KIT D816V mutation can be found using a blood test in adults who have had anaphylaxis or systemic mast cell activation symptoms.

    We break down why KIT D816V matters, how it connects to systemic mastocytosis, why HaT needs to be considered, and how newer blood tests may help doctors catch clonal mast cell disease earlier.

    What we cover in our episode about KIT D816V and anaphylaxis:
    • Setting the stage: Understanding mast cell activation and anaphylaxis.
    • Why KIT D816V matters: How this mutation fits into clonal mast cell disease, what blood testing can reveal, and when doctors still turn to a bone marrow biopsy.
    • Making sense of tryptase and hereditary alpha-tryptasemia (HaT): Why baseline tryptase, the “20% + 2” rule, and HaT can make screening more complicated than it seems.
    • What the PROSPECTOR trial uncovered: How often KIT D816V appeared in people with anaphylaxis, and other results on tryptase and HaT.
    • How this helps patients: What these findings mean for anyone with unexplained or severe anaphylaxis, and how doctors combine KIT testing, tryptase, HaT, and symptoms to decide on next steps.

    Other podcast episodes about mast cell disease:

    • Ep. 127: Management of indolent mastocytosis - A clinical yardstick
    • Ep. 126: Management of mast cell activation syndrome - A clinical yardstick
    • Ep. 121: Avapritinib vs Placebo in Indolent Systemic Mastocytosis - PIONEER Trial
    • Ep. 118: The ISM Disconnect - Do Patients and Providers Agree on Symptom Control?
    • Ep. 70 How do stress and low histamine diets impact mast cell disease?
    • Ep. 63: Mast Cell Diseases & Systemic Mastocytosis: The Basic Science
    • Ep. 65: The Symptoms and Triggers of Mast Cell Disease

    ***********

    The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.

    ***********

    Made in partnership with The Allergy & Asthma Network.

    Thanks to Blueprint Medicines for sponsoring today’s episode.

    This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

    Show More Show Less
    44 mins
  • #137 - Diagnosing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
    Nov 20 2025

    Persistent congestion, pressure, or a reduced sense of smell often gets mistaken for allergies or a stubborn cold when it may be something more, like chronic rhinosinusitis with nasal polyps (CRSwNP). Getting the right diagnosis is the first step toward real relief.

    Dr. Tonya Farmer, a board-certified ENT, joins Kortney and Dr. G to explain how chronic rhinosinusitis with nasal polyps (CRSwNP) is diagnosed. She walks us through the full evaluation: what symptoms matter, what a nasal endoscopy actually shows, when a CT scan is needed, and how type 2 inflammation fits into the picture.

    What we cover about diagnosing CRSwNP:
    • Key symptoms: Persistent congestion, drainage, facial pressure, and especially loss of smell are major red flags for CRSwNP.
    • Why duration matters: Chronic means 12 weeks or longer. If symptoms keep coming back or never truly improve, it’s time to look deeper.
    • The physical exam: ENTs use nasal endoscopy to see swelling, mucus, or polyps that aren’t visible from the outside.
    • When CT scans are needed: Imaging helps confirm sinus inflammation and shows the extent of polyp growth.
    • Additional testing: Allergy testing, IgE levels, eosinophils, and other immune markers help identify type 2 inflammation and guide next steps.
    • When to see a specialist: If antibiotics, steroids, or over-the-counter treatments aren’t helping, ask for a referral to an allergist or ENT. Early diagnosis can prevent worsening symptoms and reduce the need for surgery.

    Set the foundations: Ep. 133: What is Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)?

    ___

    Made in partnership with The Allergy & Asthma Network.

    Thanks to Sanofi-Regeneron for sponsoring today’s episode.

    This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

    Show More Show Less
    34 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.